Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BioAge Labs (BIOA) EBITDA Margin (2025 - 2026)

BioAge Labs' EBITDA Margin history spans 1 years, with the latest figure at 842.76% for Q4 2025.

  • On a quarterly basis, EBITDA Margin changed N/A to 842.76% in Q4 2025 year-over-year; TTM through Dec 2025 was 895.74%, a N/A change, with the full-year FY2025 number at 895.74%, changed N/A from a year prior.
  • EBITDA Margin hit 842.76% in Q4 2025 for BioAge Labs, up from 978.97% in the prior quarter.
  • Over the last five years, EBITDA Margin for BIOA hit a ceiling of 842.76% in Q4 2025 and a floor of 978.97% in Q3 2025.